The molecular mechanism of thrombospondin family members in cardiovascular diseases

被引:1
作者
Pan, Heng [1 ,2 ,3 ]
Lu, Xiyi [1 ,2 ,3 ]
Ye, Di [1 ,2 ,3 ]
Feng, Yongqi [1 ,2 ,3 ]
Wan, Jun [1 ,2 ,3 ]
Ye, Jing [1 ,2 ,3 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Peoples R China
[2] Wuhan Univ, Cardiovasc Res Inst, Wuhan, Peoples R China
[3] Hubei Key Lab Cardiol, Wuhan, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2024年 / 11卷
基金
中国国家自然科学基金;
关键词
cardiovascular disease; thrombospondin; cartilage oligomeric matrix protein; myocardial remodeling; vascular remodeling; OLIGOMERIC MATRIX PROTEIN; ANGIOGENESIS INHIBITOR ABT-510; SMOOTH-MUSCLE-CELLS; REGULATORY T-CELLS; NITRIC-OXIDE; PHASE-I; ENDOPLASMIC-RETICULUM; TARGETED DELETION; BETA ACTIVATION; NADPH OXIDASE;
D O I
10.3389/fcvm.2024.1337586
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular diseases have been identified as vital factors in global morbidity and mortality in recent years. The available evidence suggests that various cytokines and pathological proteins participate in these complicated and changeable diseases. The thrombospondin (TSP) family is a series of conserved, multidomain calcium-binding glycoproteins that cause cell-matrix and cell-cell effects via interactions with other extracellular matrix components and cell surface receptors. The TSP family has five members that can be divided into two groups (Group A and Group B) based on their different structures. TSP-1, TSP-2, and TSP-4 are the most studied proteins. Among recent studies and findings, we investigated the functions of several family members, especially TSP-5. We review the basic concepts of TSPs and summarize the relevant molecular mechanisms and cell interactions in the cardiovascular system. Targeting TSPs in CVD and other diseases has a remarkable therapeutic benefit.
引用
收藏
页数:12
相关论文
共 162 条
  • [1] Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease
    Aboumsallem, Joseph Pierre
    Moslehi, Javid
    de Boer, Rudolf A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (02):
  • [2] Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]
  • [3] Proteomic characterization of human coronary thrombus in patients with ST-segment elevation acute myocardial infarction
    Alonso-Orgaz, Sergio
    Moreno-Luna, Rafael
    Lopez, Juan A.
    Gil-Dones, Felix
    Padial, Luis R.
    Moreu, Jose
    de la Cuesta, Fernando
    Barderasa, Maria G.
    [J]. JOURNAL OF PROTEOMICS, 2014, 109 : 368 - 381
  • [4] Oxidative Stress-Mediated Thrombospondin-2 Upregulation Impairs Bone Marrow-Derived Angiogenic Cell Function in Diabetes Mellitus
    Bae, Ok-Nam
    Wang, Jie-Mei
    Baek, Seung-Hoon
    Wang, Qingde
    Yuan, Hong
    Chen, Alex F.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (08) : 1920 - 1927
  • [5] Randomized, Phase II Study of the Thrombospondin-1-Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Soft Tissue Sarcoma
    Baker, Laurence H.
    Rowinsky, Eric K.
    Mendelson, David
    Humerickhouse, Rod A.
    Knight, Raymond A.
    Qian, Jiang
    Carr, Robert A.
    Gordon, Gary B.
    Demetri, George D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (34) : 5583 - 5588
  • [6] Intermittent hypoxia mediated by TSP1 dependent on STAT3 induces cardiac fibroblast activation and cardiac fibrosis
    Bao, Qiankun
    Zhang, Bangying
    Suo, Ya
    Liu, Chen
    Yang, Qian
    Zhang, Kai
    Yuan, Ming
    Yuan, Meng
    Zhang, Yue
    Li, Guangping
    [J]. ELIFE, 2020, 9
  • [7] Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation
    Bauer, Eileen M.
    Qin, Yan
    Miller, Thomas W.
    Bandle, Russell W.
    Csanyi, Gabor
    Pagano, Patrick J.
    Bauer, Philip M.
    Schnermann, Jurgen
    Roberts, David D.
    Isenberg, Jeff S.
    [J]. CARDIOVASCULAR RESEARCH, 2010, 88 (03) : 471 - 481
  • [8] Computer Simulation of TSP1 Inhibition of VEGF-Akt-eNOS: An Angiogenesis Triple Threat
    Bazzazi, Hojjat
    Zhang, Yu
    Jafarnejad, Mohammad
    Isenberg, Jeffrey S.
    Annex, Brian H.
    Popel, Aleksander S.
    [J]. FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [9] A thrombospondin-1 antagonist of transforming growth factor-β activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II
    Belmadani, Souad
    Bernal, Juan
    Wei, Chih-Chang
    Pallero, Manuel A.
    Dell'Italia, Louis
    Murphy-Ullrich, Joanne E.
    Berecek, Kathleen H.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2007, 171 (03) : 777 - 789
  • [10] Berezin Alexander E, 2015, J Biomed Res, V30, DOI 10.7555/JBR.29.20140025